Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:3347-3355

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, X.
Right arrow Articles by Ginsberg, H. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, X.
Right arrow Articles by Ginsberg, H. N.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Dietary Fats
Hazardous Substances DB
*OLEIC ACID
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:3347-3355.)
© 1997 American Heart Association, Inc.


Articles

Demonstration of Biphasic Effects of Docosahexaenoic Acid on Apolipoprotein B Secretion in HepG2 Cells

Xujun Wu; Aiming Shang; Hongshi Jiang; ; Henry N. Ginsberg

From the Department of Medicine, College of Physicians and Surgeons of Columbia University, New York, NY.

Correspondence to Henry N. Ginsberg, Department of Medicine, College of Physicians and Surgeons of Columbia University, New York, NY 10032. E-mail xw17{at}columbia.edu

Abstract Oleic acid (OA) stimulates apolipoprotein B (apoB) secretion from HepG2 cells by protecting the nascent protein from rapid intracellular degradation. In contrast, the n-3 fatty acids, docosahexaenoic acid (DHA) and eicosapentaenoic acid, have been shown to reduce apoB secretion by increasing its intracellular degradation in rat hepatocytes. We attempted to determine if OA and DHA have these opposite effects at the same point in the secretory pathway for apoB or if they act at different points in HepG2 cells. Unexpectedly, we found that when DHA (0.2 mmol/L) was incubated with HepG2 cells for 2 hours, it stimulated both triglyceride (TG) synthesis and apoB secretion significantly (the "stimulatory effect"). The stimulatory effect of DHA on apoB secretion was associated with decreased intracellular degradation of newly synthesized apoB. These acute effects of DHA on TG synthesis and apoB secretion paralleled those previously demonstrated with OA. After DHA was removed from the medium, however, both TG synthesis and apoB secretion rapidly decreased to a level that was significantly less than the control level (the "inhibitory effect"). At the same time, intracellular apoB degradation was significantly increased, and this degradation was efficiently prevented by proteasome inhibitors. Removal of DHA from the incubation resulted in inhibition of the incorporation of endogenous fatty acids into TG. In contrast, removal of OA from the media was not associated with any such inhibitory effect. The inhibitory effect of DHA on basal apoB secretion persisted at least 8 hours. These studies suggest that incubation of HepG2 cells with DHA has biphasic effects on TG synthesis and apoB secretion: an initial stimulation of TG synthesis is followed by inhibition of TG synthesis and increased apoB degradation. Although the stimulatory effect of DHA is apparent during short incubations of HepG2 cells, both effects would be expected to occur during long incubations, since fatty acid uptake by cells is rapid and efficient. Thus, long incubations of HepG2 cells with DHA could result in overall reduced apoB secretion compared with cells incubated in bovine serum albumin. If these findings are extrapolated to the in vivo situation, they can explain the ability of dietary n-3 fatty acids, which would be delivered to the liver intermittently, to reduce very low density lipoprotein secretion.


Key Words: apolipoprotein B • n-3 fatty acids • HepG2 cells




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
B. H.-J. Chang, L. Li, A. Paul, S. Taniguchi, V. Nannegari, W. C. Heird, and L. Chan
Protection against Fatty Liver but Normal Adipogenesis in Mice Lacking Adipose Differentiation-Related Protein
Mol. Cell. Biol., February 1, 2006; 26(3): 1063 - 1076.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
T. R. Overton and M. R. Waldron
Nutritional Management of Transition Dairy Cows: Strategies to Optimize Metabolic Health
J Dairy Sci, July 1, 2004; 87(13_suppl): E105 - 119.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. Le Petit-Thevenin, N. Bruneau, A. Nganga, D. Lombardo, and A. Verine
Effects of arachidonic and docosahexaenoic acids on secretion and degradation of bile salt-dependent lipase in AR4-2J cells
J. Lipid Res., August 1, 2001; 42(8): 1220 - 1230.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Bradbury, C. J. Mann, S. Kochl, T. A. Anderson, S. A. Chester, J. M. Hancock, P. J. Ritchie, J. Amey, G. B. Harrison, D. G. Levitt, et al.
A Common Binding Site on the Microsomal Triglyceride Transfer Protein for Apolipoprotein B and Protein Disulfide Isomerase
J. Biol. Chem., January 29, 1999; 274(5): 3159 - 3164.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
H. Jiang, H. N. Ginsberg, and X. Wu
Glucose does not stimulate apoprotein B secretion from HepG2 cells because of insufficient stimulation of triglyceride synthesis
J. Lipid Res., November 1, 1998; 39(11): 2277 - 2285.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
F. Nassir, D. K. Bonen, and N. O. Davidson
Apolipoprotein(a) Synthesis and Secretion from Hepatoma Cells Is Coupled to Triglyceride Synthesis and Secretion
J. Biol. Chem., July 10, 1998; 273(28): 17793 - 17800.
[Abstract] [Full Text] [PDF]